Patents by Inventor Elvar Örn VIKTORSSON

Elvar Örn VIKTORSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11958842
    Abstract: A combination product comprising a carbapenem and a compound of formula (I?), or a pharmaceutically acceptable salt thereof: a pharmaceutical composition comprising the combination product; and methods of treating bacterial or fungal infections using the combination product and pharmaceutical composition.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: April 16, 2024
    Assignee: ADJUTEC PHARMA AS
    Inventors: Pål Rongved, Ove Alexander Høgmoen Åstrand, Elvar Ørn Viktorsson, Ørjan Samuelson, Adam Heikal, Ole Andreas Løchen Økstad, Geir Kildahl-Andersen
  • Publication number: 20210292313
    Abstract: A combination product comprising a carbapenem and a compound of formula (I?), or a pharmaceutically acceptable salt thereof: a pharmaceutical composition comprising the combination product; and methods of treating bacterial or fungal infections using the combination product and pharmaceutical composition.
    Type: Application
    Filed: April 26, 2021
    Publication date: September 23, 2021
    Inventors: Pål Rongved, Ove Alexander Høgmoen Âstrand, Adam Heikal, Elvar Ørn Viktorsson
  • Patent number: 11046678
    Abstract: Compounds of formula (Ia) or (Ib), or a pharmaceutically acceptable salt thereof, pharmaceutical compositions comprising the compounds, and methods of treatment using the compounds.
    Type: Grant
    Filed: December 18, 2017
    Date of Patent: June 29, 2021
    Inventors: Pål Rongved, Ove Alexander Høgmoen Åstrand, Adam Heikal, Elvar Ørn Viktorsson
  • Publication number: 20200095237
    Abstract: The invention provides compounds of general formula (I?), and their pharmaceutically acceptable salts: wherein: Z is a group having the formula: -T-S-A-Y in which: T is a group selected from —O—, —NH—, —S—, —(XCR7R8)— (where R7 and R8 is independently —H or C1-3 alkyl and X is selected from from —O—, —NH—, —S—); S is —(C?O)—, —(SO2)—, —(PO2)—; A, —O—, —NH—, —S— or —NH(CO)—, —(CR7R8X)— (where R7 and R8 is independently —H or C1-3 alkyl and X is selected from from —O—, —NH—, —S—), -T-S-A- is a group susceptible to hydrolytic and/or enzymatic cleavage in vivo to leave a group selected from —OH, —NH2, —SH, —COOH, —CONH2, —O—(CR7R8)—COOH and —(CR7R8)—CONH2; Y is one or more targeting groups or a lipophilic or hydrophilic group affecting the solubility in water and the biodistribution in a living organism or a living cell; R1-R6 are independently selected from hydrogen, halogen (e.g. F, Cl, Br, I), lower alkyl (e.g.
    Type: Application
    Filed: December 18, 2017
    Publication date: March 26, 2020
    Inventors: Pål RONGVED, Ove Alexander Høgmoen ÅSTRAND, Adam HEIKAL, Elvar Ørn VIKTORSSON
  • Patent number: 9745273
    Abstract: Novel phenazine derivatives, methods for their preparation and their medical use, in particular as anti-neoplastic agents and anti-infective agents, are provided. Novel methods for the preparation of iodinin and myxin are also provided.
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: August 29, 2017
    Assignees: Universitetet I Oslo, Bergen Teknologioverføring AS, Université Claude Bernard Lyon 1
    Inventors: Stein Ove Døskeland, Pål Rongved, Lars Herfindal, Marc Le Borgne, Elvar Örn Viktorsson, Ove Alexander Høgmoen Åstrand
  • Publication number: 20160251320
    Abstract: Novel phenazine derivatives, methods for their preparation and their medical use, in particular as anti-neoplastic agents and anti-infective agents, are provided. Novel methods for the preparation of iodinin and myxin are also provided.
    Type: Application
    Filed: November 3, 2014
    Publication date: September 1, 2016
    Inventors: Stein Ove DØSKELAND, Pål RONGVED, Lars HERFINDAL, Marc LE BORGNE, Elvar Örn VIKTORSSON, Ove Alexander Høgmoen ÅSTRAND